STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
STAT3 反义寡核苷酸 AZD9150 在部分接受过大量预处理的淋巴瘤患者中的疗效:一项 1b 期试验的结果
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-018-0436-5
Reilley, Matthew J; McCoon, Patricia; Cook, Carl; Lyne, Paul; Kurzrock, Razelle; Kim, Youngsoo; Woessner, Richard; Younes, Anas; Nemunaitis, John; Fowler, Nathan; Curran, Michael; Liu, Qinying; Zhou, Tianyuan; Schmidt, Joanna; Jo, Minji; Lee, Samantha J; Yamashita, Mason; Hughes, Steven G; Fayad, Luis; Piha-Paul, Sarina; Nadella, Murali V P; Xiao, Xiaokun; Hsu, Jeff; Revenko, Alexey; Monia, Brett P; MacLeod, A Robert; Hong, David S